Meeting Einstein: Hans Schreiber

Medicine gets personal - gene-based therapies for a new era in treatment?

Panel discussion with internationally renowned scientists including Nobel Laureate  Bruce Beutler and Einstein Visiting Fellow Hans Schreiber

Photo: Fotolia #50721167

Research in the field of "personalised medicine" inspires high hopes. Its aim is to provide customized therapies for patients based on their individual genetic code. Diseases such as cancer, diabetes or cardiovascular disorders could be detected earlier, more effectively and with fewer side effects. In the long term, the goal is to prevent these diseases from developing in the first place. But how exactly does this approach work? What lessons have been learned so far? What are the the prospects? What are the constraints? In an open dialogue with internationally renowned scientists, Einstein Visiting Fellow Hans Schreiber will discuss the main challenges of personal or "precision" medicine, as it is often called.

Panelists

  • Bruce Beutler
    Immunologist and geneticist, University of Texas Southwestern, Nobel Laureate in Physiology or Medicine 2011
  • Erwin Böttinger
    Professor of Personalized Medicine at Charité - Universitätsmedizin Berlin, Chairman of the Berlin Institute of Health
  • Manfred Dietel
    Director of the Institute of Pathology at Charité - Universitätsmedizin Berlin, Vice-Chairman Berlin Cancer Society
  • Angelika Eggert
    Director of the Department of Paediatrics at Charité – Universitätsmedizin Berlin, Einstein Professorin
  • Nikolaus Rajewsky
    Professor for Systems Biology, Max Delbrück Center for Molecular Medicine
  • Hans Schreiber
    Einstein Visiting Fellow

Hans Schreiber

Photo: Rockefeller University Press Mosimann for Balzan/Rockefeller University Press

The event takes place as a part of the Einstein Visiting Fellowships of Hans Schreiber. The professor of pathology is one of the most renowned experts in the fight against cancer. After completing his studies in Freiburg he continued his career in the US, where he taught at the University of California at Berkeley. As chairman of the Committee for Immunology at the University of Chicago Schreiber developed a new laser scanning method that makes it possible for the first time to observe tissue of cancer cells on a living organism. This provides valuable insights on the functioning of individual cancer cells.